| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |